Diabetic Retinopathy Medication, Drugs & Medicine

Latest Health Related News:
Aclasta(R) Receives European Approval As First Once-yearly Treatment For Postmenopausal Osteoporosis
Aclasta® (zoledronic acid 5 mg) has gained European Union approval as the first and only once-yearly treatment for women with postmenopausal osteoporosis. The announcement closely follows the recent approval in the US, where the Food and Drug Administration (FDA) approved Aclasta under the brand name Reclast® in August 2007. The European Commission decision applies to all 27 member states, Norway and Iceland.
Emergency In Emergency, Australia
Media reports of a crisis in NSW public hospital emergency departments are indicative of a bigger nation-wide problem, according to the AMA.Emergency Physician representative on the AMA Federal Council, Dr David Mountain, said that until recently all Australian governments have ignored the medical workforce, particularly medical training.
Scientists Find 10 Genes That May Play A Role In The Progression Of ALS
Blood samples from more than 220 ALS patients at the Methodist Neurological Institute were used in research that revealed significant changes in or around 10 specific genes in sporadic ALS, the most common form of ALS. The results were published this week in the New England Journal of Medicine."This discovery has helped identify new biological pathways for the progression of ALS in individuals with this debilitating disease," said Dr.